AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
STREPTOKINASE
8 registrations across 6 African markets— 7 active
Markets with STREPTOKINASE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| STPase Injection Powder for Injection | 🇿🇲Zambia | Cadila Pharmaceuticals Limited | active | May 2029 |
| MYOKINASE 1,500,000 IU/VIAL INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2017 |
| FIBREAKER 1 500 000 I.U. | 🇿🇦South Africa | Gen-Eye (Pty) Ltd | active | Jan 1900 |
| Thromboflux (Lyophilized) Injection | 🇹🇿Tanzania | Bharat Serums and Vaccines Limited | active | — |
| STREPTASE 1500 000 UI POUDRE POUR USAGE PARENTERAL | 🇲🇦Morocco | — | active | — |
| SEDONASE SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| STREPTASE poudre pour préparation injectable / 1500000 UI | 🇸🇳Senegal | BOOTS HEALTHCARE | active | — |
| STREPTASE 750 000 UI POUDRE POUR USAGE PARENTERAL | 🇲🇦Morocco | — | active | — |
STREPTOKINASE in Africa — Regulatory Overview
STREPTOKINASE is registered across 6 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Malawi, Senegal, Tanzania and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.